News & Analysis on Clinical Trial Services & Contract Research And Development
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Elan, Inspire Pharmaceuticals, BioVex and Lux Biosciences.
UK API maker Aesica has bought formulation firm R5 Pharmaceuticals, continuing the expansion strategy it has employed over the last few years.
Chemicals manufacturer BASF reorganises Swiss business to cut active pharmaceutical ingredient (API) manufacturing site complexity and simplify process operations.
The potential of microbial cells as producers of nanomaterials has been underestimated and further research is needed to improve the situation, according to an academic.
PSR has launched OrphanIQ to provide biopharm with a quick, simple means of answering short questions about orphan drug development.
Ireland-based Firecrest Clinical says focusing on trial specific training and visits for principal investigators can speed recruitment, cut protocol deviations and produce cleaner data.